News

Solarvest BioEnergy Inc.

439 Helmcken Street
Vancouver, BC
V6B 2E6
Canada

About Solarvest

Solarvest is committed to the development of sustainable and renewable energy sources to meet growing energy demands and environmental challenges. Solarvest's intellectual property is a biologically-based hydrogen producing technology, which provides a method for controlling key genes in algae resulting in the continuous production of hydrogen gas. Solarvest's bio-energy production system utilizes light and carbon dioxide to produce hydrogen leaving a clean positive environmental footprint.

For further information contact:

Gerri Greenham
Chief Executive Officer
T: +1 (416) 420-0947
E: Gerri Greenham

NEWS ARCHIVES

December 13, 2017
Form of proxy – English

December 13, 2017
Management information circular – English

December 13, 2017
Notice of meeting – English

December 13, 2017
Other

November 23, 2017
52-109FV1 – Certification of annual filings – CEO (E)

JNovember 23, 2017
52-109FV1 – Certification of annual filings – CFO (E)

November 23, 2017
MD&A – English

November 23, 2017
AB Form 13-501F1 (Class 1 and 3B Reporting Issuers – Participation Fee)

November 23, 2017
Audited annual financial statements – English

November 23, 2017
ON Form 13-502F1 (class 1 and 3B Reporting Issuers – Participation Fee)

November 3, 2017
Notice of the meeting and record date – English

October 17, 2017
News release – English

October 11, 2017
News release – English

September 17, 2015
Solarvest’s NanuqTM Organic Omega-3 Receives FDA Approval

SEDAR
AN ARCHIVED LIST OF ALL FINANCIAL RECORDS AND NEWS RELEASES FOR SOLARVEST BIOENERGY INC. CAN BE FOUND AT WWW.SEDAR.COM

Spotlight

Solarvest BioEnergy specializes in the manipulation, growth and production of Chlamydomonas reinhardtii (below)